AllianceBernstein’s MacroGenics MGNX Stock Holding History

AllianceBernstein’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-102,730	Closed	-$130K	–	3288
2025 Q1	$130K	Hold	102,730	–	–	﹤0.01%	3022
2024 Q4	$334K	Hold	102,730	–	–	﹤0.01%	2814
2024 Q3	$338K	Hold	102,730	–	–	﹤0.01%	2859
2024 Q2	$437K	Buy	102,730 +35,700	+53%	+$348K	﹤0.01%	2738
2024 Q1	$987K	Sell	67,030 -40,570	-38%	-$613K	﹤0.01%	2275
2023 Q4	$1.04M	Hold	107,600	–	–	﹤0.01%	2258
2023 Q3	$501K	Hold	107,600	–	–	﹤0.01%	2567
2023 Q2	$576K	Hold	107,600	–	–	﹤0.01%	2560
2023 Q1	$771K	Hold	107,600	–	–	﹤0.01%	2351
2022 Q4	$722K	Buy	107,600 +12,700	+13%	+$69.6K	﹤0.01%	2446
2022 Q3	$328K	Sell	94,900 -8,500	-8%	-$32.5K	﹤0.01%	2825
2022 Q2	$305K	Sell	103,400 -42,531	-29%	-$224K	﹤0.01%	2874
2022 Q1	$1.29M	Buy	145,931 +63,331	+77%	+$699K	﹤0.01%	2324
2021 Q4	$1.33M	Sell	82,600 -1,600	-2%	-$30.1K	﹤0.01%	2353
2021 Q3	$1.76M	Hold	84,200	–	–	﹤0.01%	2235
2021 Q2	$2.26M	Hold	84,200	–	–	﹤0.01%	2124
2021 Q1	$2.68M	Buy	84,200 +1,600	+2%	+$38.9K	﹤0.01%	1911
2020 Q4	$1.89M	Hold	82,600	–	–	﹤0.01%	2021
2020 Q3	$2.08M	Sell	82,600 -1,200	-1%	-$32.8K	﹤0.01%	1827
2020 Q2	$2.34M	Buy	83,800 +8,400	+11%	+$146K	﹤0.01%	1755
2020 Q1	$439K	Buy	75,400 +10,900	+17%	+$99K	﹤0.01%	2418
2019 Q4	$702K	Hold	64,500	–	–	﹤0.01%	2414
2019 Q3	$823K	Hold	64,500	–	–	﹤0.01%	2331
2019 Q2	$1.09M	Buy	64,500 +22,800	+55%	+$392K	﹤0.01%	2279
2019 Q1	$750K	Hold	41,700	–	–	﹤0.01%	2378
2018 Q4	$530K	Hold	41,700	–	–	﹤0.01%	2455
2018 Q3	$894K	Hold	41,700	–	–	﹤0.01%	2381
2018 Q2	$861K	Hold	41,700	–	–	﹤0.01%	2388
2018 Q1	$1.05M	Sell	41,700 -1,300	-3%	-$31.6K	﹤0.01%	2228
2017 Q4	$817K	Hold	43,000	–	–	﹤0.01%	2379
2017 Q3	$795K	Hold	43,000	–	–	﹤0.01%	2386
2017 Q2	$753K	Buy	43,000 +2,400	+6%	+$45.8K	﹤0.01%	2446
2017 Q1	$755K	Sell	40,600 -2,800	-6%	-$54K	﹤0.01%	2378
2016 Q4	$887K	Hold	43,400	–	–	﹤0.01%	2319
2016 Q3	$1.3M	Sell	43,400 -600	-1%	-$17.8K	﹤0.01%	2079
2016 Q2	$1.19M	Buy	44,000 +3,600	+9%	+$81.2K	﹤0.01%	2122
2016 Q1	$758K	Hold	40,400	–	–	﹤0.01%	2247
2015 Q4	$1.25M	Sell	40,400 -1,345	-3%	-$40.9K	﹤0.01%	1987
2015 Q3	$894K	Buy	41,745 +3,545	+9%	+$111K	﹤0.01%	2224
2015 Q2	$1.45M	Buy	38,200 +6,500	+21%	+$214K	﹤0.01%	2058
2015 Q1	$994K	Hold	31,700	–	–	﹤0.01%	2188
2014 Q4	$1.11M	Buy	31,700 +14,500	+84%	+$361K	﹤0.01%	2150
2014 Q3	$359K	Buy	17,200 +1,800	+12%	+$37.2K	﹤0.01%	2608
2014 Q2	$335K	Buy	15,400 +12,300	+397%	+$259K	﹤0.01%	2642
2014 Q1	$86K	Buy	+3,100	New	+$109K	﹤0.01%	3011

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein's MGNX Position: Q2 2025 in Review

AllianceBernstein sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 102,730 shares — an estimated $130K sold.

AllianceBernstein first reported a position in MGNX in Q1 2014 and held it in 45 quarters. The position peaked at $2.68M in Q1 2021. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

AllianceBernstein reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 102,730 MacroGenics shares in Q2 2025, an estimated $130K.
AllianceBernstein first reported a position in MacroGenics in Q1 2014 and held it in 45 quarters.
AllianceBernstein's MacroGenics position peaked at $2.68M in Q1 2021.
112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.